2Smith JFM,Cleutjens JPM,Van Krimpen,et al.Cardiac remodeling in hypertension and following myocardial infarction:effects of arteriolar vasodilators.Basic research in cardiology[J].1991,86(suppll):134-139.
3Weber KT,Brilla CG.Pathological hypertrophy and cardiac interstitium[J].Circulation,1991,83(6):1849-1865.
4Gian Paolo Rossi,Alfredo Sacchetto,Maurizio Cesari,et al.Interactions between endothelin-1 and the rennin-angiotensin-aldosterone system[J].Cardiovascular Research,1999,43:300-307.
5Bader M,Peters J,Baltatu O,et al.Tissue renin-angiotensin systems:new insights from experimental animal models in hypertension research[J].Journal of molecular medicine,2001,79:76-102.
6Remuzzi G,Perico N,Benigni A.New therapeutics that antagonize endothelin:promises and frustrations[J].Nature reviews.Drug discovery,2002,1:986-1001.
7Schiffrin EL.Endothelin:potential role in hypertension and vascular hypertrophy[J].Hypertension,1995,25:1135-1143.
8Lariviere R,Lebel M.Endothelin-1 in chronic renal failure and hypertension[J].Canadian journal of physiology and pharmacology,2003,81(6):607-621.
9David M,Pollock.Endothelin,Angiotensin and oxidative stress in hypertension[J].Hypertension,2005,45:477.
10Cohuet G,Struijker-Boudier H.Mechanisms of target organ damage caused by hypertension:therapeutic potential[J].Pharmacology & Therapeutics,2006,111(1):81-98.
